Namsa competitors

Zippia score 4.2

Namsa main competitors are Illumina, PacBio, and Sanofi Genzyme.

Competitor Summary. See how Namsa compares to its main competitors:

Sanofi Genzyme has the most employees (12,000).
Employees at Illumina earn more than most of the competitors, with an average yearly salary of $94,044.
The oldest company is Fujirebio Europe, founded in 1950.

Work at Namsa?

Share your experience

Namsa vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Namsa	1967	4.2	Northwood, OH	5	$13.0M	142
Scintillon Institute	2012	3.8	San Diego, CA	1	$4.3M	41
CryoLife	1984	4.7	Kennesaw, GA	2	$253.2M	1,000
Mérieux NutriSciences	1967	3.6	Chicago, IL	15	$117.8M	8,000
Medimmune	1987	4.7	Gaithersburg, MD	1	$422.2M	6,030
Advanced Sterilization Products	1987	4.5	Irvine, CA	1	$83.0M	1,074
Caliper Life Sciences	1995	4.5	Hopkinton, MA	1	$109.8M	200
Fujirebio Europe	1950	4.1	Malvern, PA	1	$94.8M	7,500
AIBioTech	1992	3.3	Richmond, VA	1	$1.1M	29
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Luminex	1995	4.7	Austin, TX	3	$417.4M	1,140
Promega	1978	4.7	Madison, WI	2	$450.0M	1,601
T2 Biosystems	2006	4.1	Lexington, MA	2	$7.2M	182
Instrumentation Laboratory	1959	4.8	Bedford, MA	2	$1.0B	3,000
Illumina	1998	4.8	San Diego, CA	5	$4.4B	7,800
PacBio	2004	4.7	Menlo Park, CA	1	$154.0M	400
Genencor International	1982	4.4	Palo Alto, CA	1	$380.0M	1,500
Morphotek	2000	3.7	Exton, PA	1	$4.8M	1
Abbott Molecular	1989	4.3	Des Plaines, IL	1	$74.5M	125
DiaSorin Inc.	1975	4.5	Stillwater, MN	3	$722.5M	1,939
LGC Biosearch Technologies	1993	4.3	Petaluma, CA	1	$75.0M	100

Rate Namsa's competitiveness in the market.

Namsa salaries vs competitors

Among Namsa competitors, employees at Illumina earn the most with an average yearly salary of $94,044.

Compare Namsa salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Namsa	$70,268	$33.78	-
Scintillon Institute	$76,457	$36.76	-
CryoLife	$54,541	$26.22	-
Mérieux NutriSciences	$52,202	$25.10	-
Medimmune	$78,540	$37.76	-
Advanced Sterilization Products	$77,471	$37.25	-

Compare Namsa job title salaries vs competitors

Company	Highest salary	Hourly salary
Namsa	$100,742	$48.43
Medimmune	$103,730	$49.87
AIBioTech	$103,718	$49.86
Abbott Molecular	$103,546	$49.78
T2 Biosystems	$101,512	$48.80
Advanced Sterilization Products	$101,146	$48.63
Genencor International	$100,636	$48.38
Instrumentation Laboratory	$99,401	$47.79
Illumina	$99,015	$47.60
Promega	$98,870	$47.53
LGC Biosearch Technologies	$98,294	$47.26
DiaSorin Inc.	$98,235	$47.23
Sanofi Genzyme	$97,617	$46.93
Fujirebio Europe	$97,152	$46.71
Luminex	$96,298	$46.30
Morphotek	$96,069	$46.19
Mérieux NutriSciences	$94,983	$45.66
Caliper Life Sciences	$92,676	$44.56
CryoLife	$85,261	$40.99
Scintillon Institute	$82,226	$39.53

Do you work at Namsa?

Is Namsa able to compete effectively with similar companies?

Namsa jobs

Namsa demographics vs competitors

Compare gender at Namsa vs competitors

Job title	Male	Female
CryoLife	41%	59%
Sanofi Genzyme	51%	49%
Luminex	59%	41%
Illumina	62%	38%
PacBio	65%	35%
Namsa	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Namsa vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
CryoLife	52%	11%	23%	12%	3%	9.5
Illumina	46%	23%	7%	20%	5%	9.7
Luminex	48%	23%	11%	14%	3%	9.8
PacBio	42%	20%	5%	27%	5%	9.6
Sanofi Genzyme	61%	14%	7%	14%	4%	9.8
Medimmune	48%	12%	17%	18%	5%	9.9

Namsa and similar companies CEOs

CEOBio

J. Patrick MacKin

CryoLife

Francis A. Desouza

Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Nachum Shamir

Luminex

With a proven track record of bringing game-changing technologies to the market, Mr. Shamir joined Luminex Corporation as President, Chief Executive Officer, and Board Member in 2014. From 2006 to 2014, Mr. Shamir served as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Exalenz Bioscience Ltd. (TASE: EXEN). He has previously served as a Board Member at Scitex Corporation, Cogentix Medical (NASDAQ: CGNT), recently acquired by Laborie Medical Technologies, and invendo medical GmBH, now part of Ambu. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Christian O. Henry

PacBio

John J. Sperzel

T2 Biosystems

Carlo Rosa

DiaSorin Inc.

Carlo Rosa is a CEO/General Manager at Diasorin, Board Member at Diasorin, and Chief Executive Officer at Diasorin GmbH. He has worked as Chief Operating Officer at Diasorin. Carlo works or has worked at Incstar Corp and works or has worked as Partner at Bioinvestment SA, Board Member at Sarago Srl, and Partner at Cid Investments Srl. He attended Unito.

Paul Hudson

Sanofi Genzyme

Speck Loe

Medimmune

Speck Loe works at Medimmune and a Ceo at Medimmune and is based in Granite Falls, Washington.

Dr Nicholas Nicolaides

Morphotek

Tim Robinson

LGC Biosearch Technologies